EXE(EXE)
EXE
Q4 2026 EPS Estimate
$1.47
Oct 27, 2026 · Reports after close
Revenue Estimate
$2.98B
FY2026E EPS$9.16
FY2027E EPS$8.75
Analyst Sentiment
Wall St. Consensus
Buy19 analysts·Moderate coverage
71
Score
15 Buy (79%)4 Hold (21%)0 Sell (0%)
Rating Breakdown
Strong Buy
15%
Buy
1474%
Hold
421%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$93.00
-2.5%
Consensus
$123.00
+29.0%
Bull
$141.00
+47.9%
12-Month Target Range19 analysts
$93.00$123.00$141.00
Current $95.36Consensus
Current Price
$95.36
Upside to Consensus
$27.64
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-2.96%
EPS-4.44%
FY2028
Rev+4.55%
EPS+15.06%
FY2029
Rev+6.65%
EPS+2.99%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $13.61B | $13.21B | $13.81B | $14.72B | $15.19B |
| Low | $13.21B | $12.75B | $11.34B | $13.60B | $14.03B |
| High | $13.98B | $13.65B | $17.42B | $17.17B | $17.71B |
| EBITDA Avg | $7.65B | $7.42B | $7.76B | $8.28B | $8.54B |
| Low | $7.43B | $7.17B | $6.38B | $7.65B | $7.89B |
| High | $7.86B | $7.67B | $9.79B | $9.65B | $9.96B |
| EBIT Avg | $4.52B | $4.38B | $4.58B | $4.89B | $5.04B |
| Low | $4.39B | $4.23B | $3.76B | $4.52B | $4.66B |
| High | $4.64B | $4.53B | $5.78B | $5.70B | $5.88B |
| Net Income Avg | $2.13B | $2.16B | $2.38B | $2.49B | $3.32B |
| Low | $1.92B | $1.79B | $1.33B | $2.25B | $2.99B |
| High | $2.40B | $2.49B | $4.14B | $3.03B | $4.04B |
| EPS Avg | $9.16 | $8.75 | $10.07 | $10.37 | $13.81 |
| Low | $7.99 | $7.43 | $5.55 | $9.35 | $12.44 |
| High | $9.97 | $10.38 | $17.22 | $12.61 | $16.79 |
| Analysts (Rev / EPS) | 6 / 11 | 7 / 14 | 6 / 11 | 4 / 4 | 3 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.98B | $3.34B | $3.47B | $3.06B | $3.19B | $3.52B | $3.64B | $3.22B |
| Low | $2.73B | $3.10B | $3.27B | $2.89B | $3.01B | $3.32B | $3.43B | $3.04B |
| High | $3.14B | $3.53B | $3.61B | $3.19B | $3.33B | $3.67B | $3.79B | $3.36B |
| EBITDA Avg | $1.68B | $1.88B | $1.95B | $1.72B | $1.79B | $1.98B | $2.04B | $1.81B |
| Low | $1.53B | $1.74B | $1.84B | $1.62B | $1.69B | $1.87B | $1.93B | $1.71B |
| High | $1.77B | $1.99B | $2.03B | $1.80B | $1.87B | $2.06B | $2.13B | $1.89B |
| EBIT Avg | $991M | $1.11B | $1.15B | $1.02B | $1.06B | $1.17B | $1.21B | $1.07B |
| Low | $906M | $1.03B | $1.09B | $959M | $999M | $1.10B | $1.14B | $1.01B |
| High | $1.04B | $1.17B | $1.20B | $1.06B | $1.10B | $1.22B | $1.26B | $1.12B |
| Net Income Avg | $350M | $562M | $685M | $388M | $431M | $630M | $786M | $507M |
| Low | $202M | $430M | $634M | $360M | $399M | $583M | $728M | $469M |
| High | $438M | $672M | $722M | $409M | $455M | $664M | $829M | $535M |
| EPS Avg | $1.47 | $2.36 | $2.87 | $1.63 | $1.81 | $2.64 | $3.30 | $2.13 |
| Low | $0.85 | $1.80 | $2.66 | $1.51 | $1.67 | $2.45 | $3.05 | $1.97 |
| High | $1.84 | $2.82 | $3.03 | $1.72 | $1.91 | $2.79 | $3.48 | $2.24 |
| Analysts (Rev / EPS) | 5 / 13 | 5 / 12 | 4 / 5 | 4 / 5 | 4 / 5 | 4 / 5 | 3 / 6 | 3 / 6 |